GOLD SPONSOR

Since 1985, we’ve made it our mission to help address the treatment needs and transform the sight of people across the globe.

Since the exciting news of Lumibird’s acquisition and merger of Ellex and Quantel Medical, our global focus continues to remain committed to providing innovative world-class ophthalmic technologies, dedicated to the diagnosis and treatment of leading causes of blindness worldwide: glaucoma, cataracts, AMD and diabetic retinopathy.